Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

Citius Holds Webinar Series On Conducting Mino-Lok Phase 3 Trial During COVID-19

By PR Newswire
Dec 15, 2020 9:40 AM EST

Citius Pharmaceuticals Receives FDA Response And Guidance To Pre-IND Consultation Submission For Mino-Wrap

By PR Newswire
Dec 9, 2020 9:40 AM EST

Citius Pharmaceuticals Subsidiary NoveCite Announces Data From A Study Of Induced Mesenchymal Stem Cell ("i-MSC") Therapy In An In Vivo Model Of Acute Respiratory Distress Syndrome ("ARDS")

By PR Newswire
Dec 8, 2020 9:15 AM EST

Citius Pharmaceuticals To Present Corporate Update At Benzinga Global Small Cap Conference On December 8

By PR Newswire
Dec 3, 2020 3:30 PM EST

Citius Announces Results Of Study That Mino-Lok Eradicates S. Aureus Biofilm More Effectively And Expeditiously Than Components

By PR Newswire
Nov 30, 2020 9:15 AM EST

Citius Pharmaceuticals To Present At Virtual Fall Investor Summit

By PR Newswire
Nov 10, 2020 9:30 AM EST

Citius Pharmaceuticals To Present At H.C. Wainwright 6th Annual Israel Conference

By PR Newswire
Nov 9, 2020 9:30 AM EST

Citius Pharmaceuticals Issues October 2020 Letter To Shareholders

By PR Newswire
Oct 27, 2020 9:00 AM EDT

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) To NoveCite For COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) And Other Acute Respiratory Conditions

By PR Newswire
Oct 13, 2020 7:30 AM EDT

Citius's Mino-Lok Trial Sites Resupplied With Registration Batch Product

By PR Newswire
Sep 30, 2020 9:45 AM EDT

Citius Pharmaceuticals Reports Positive Results From Recent Data Monitoring Committee Meeting For Mino-Lok Phase 3 Trial

By PR Newswire
Sep 29, 2020 10:17 AM EDT

Citius Pharmaceuticals Achieves Chemical Manufacturing And Control Milestones For Mino-Lok®

By PR Newswire
Sep 22, 2020 8:15 AM EDT

Citius Files Addendum To Mino-Lok Phase 3 Trial Record Keeping Protocol To Advance Trials With COVID-19 Compliance

By PR Newswire
Sep 15, 2020 10:17 AM EDT

Citius Pharmaceuticals To Present At H.C. Wainwright Virtual 22nd Annual Global Investment Conference

By PR Newswire
Sep 8, 2020 10:00 AM EDT

Citius Pharmaceuticals To Present At The LD 500 Virtual Conference

By PR Newswire
Aug 27, 2020 9:00 AM EDT

Citius Pharmaceuticals Announces Improved Design And Expansion Of Intellectual Property For Mino-Wrap

By PR Newswire
Aug 26, 2020 10:00 AM EDT

Citius Pharmaceuticals To Present At The MoneyShow Las Vegas Virtual Expo

By PR Newswire
Aug 13, 2020 9:45 AM EDT

Citius Pharmaceuticals Announces Closing Of $9.6 Million Bought Deal Offering And Full Exercise Of Underwriter's Option To Purchase Additional Shares

By PR Newswire
Aug 10, 2020 3:18 PM EDT

Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering To $8.4 Million

By PR Newswire
Aug 5, 2020 9:00 PM EDT

Citius Pharmaceuticals Announces $6.0 Million Bought Deal Offering

By PR Newswire
Aug 5, 2020 5:32 PM EDT

Citius Submits Mino-Wrap Briefing Package To FDA For Pre-IND Consult

By PR Newswire
Aug 4, 2020 8:17 AM EDT

Citius Pharmaceuticals Forms Scientific Advisory Board For The Planned Development Of Its Proprietary Treatment For Acute Respiratory Disease Associated With COVID-19

By PR Newswire
Jul 22, 2020 10:30 AM EDT

Citius Pharmaceuticals To Present At The MoneyShow Accredited Investor Virtual Event

By PR Newswire
Jul 20, 2020 2:00 PM EDT

Citius Pharmaceuticals Brings On Myron S. Czuczman, M.D. As Chief Medical Officer (CMO) And Executive Vice President

By PR Newswire
Jul 14, 2020 8:47 AM EDT

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.